ArticleCureus2025
Assessment of Post-treatment Quality of Life in Breast Cancer Patients Using the EORTC QLQ-C30: A Prospective Observational Study.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundBreast cancer is the most common cancer among Indian women. Although advances in treatment have improved survival rates, many patients continue to face physical and emotional difficulties that impact quality of life (QOL) even after completing therapy. This study aimed to assess the QOL in breast-cancer patients three months after treatment using the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30).
methodsA prospective observational study was conducted on 100 breast-cancer patients at Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh. Patients were assessed three months after treatment completion. Sociodemographic and clinical details were recorded. QOL was measured using the EORTC QLQ-C30. Descriptive statistics were performed. Parametric tests were applied for continuous variables with normal distribution; otherwise, non-parametric tests were used. Pearson's and Spearman's correlation coefficients, along with multiple regression modelling, were used wherever applicable. Results: Mean age of study population was 51.02±12.16 years. Mean Global Health Score (GHS) QOL score was 55.17± 13.75, which was lower than the EORTC reference value of 61.8 ±24.6. Among functional scales, the best score was for emotional functioning (EF) (91.00 ± 11.22) while social functioning (SF) scored the lowest (74.33± 18.26). Pain, insomnia, and fatigue were the most worrisome symptoms. Elder age negatively affected GHS, physical functioning (PF), and cognitive functioning (CF). Being married had a significant positive impact on GHS, PF, and role functioning (RF). Living in a nuclear family and having an occupation have a significant positive impact on GHS.
conclusionsThere were many factors which were related to lower QOL, including age, marital status, occupation status, and type of family. This study highlights the women at risk of a poorer QOL after breast-cancer treatment in Indian society.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.